Plasma amyloid‐β Oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer’s dementia: Findings from the GMCII cohort
Plasma OAβ may be a feasible indicator of AD progression in clinical practice and a potential marker in clinical trials.
Authors
- Sang-Yun Kim (ORCID: https://orcid.org/0000-0002-2952-5404)
- Xin Yu (ORCID: https://orcid.org/0000-0001-9890-5489)
- Huali Wang (ORCID: https://orcid.org/0000-0002-3213-6493)
- Yuhan Xie (ORCID: https://orcid.org/0009-0000-2846-6556)
- Yaonan Zheng (ORCID: https://orcid.org/0000-0003-0312-9857)
- Chen Zhang (ORCID: https://orcid.org/0000-0002-3306-9317)
- Haifeng Zhang (ORCID: https://orcid.org/0000-0002-9890-8345)
- Tao Li (ORCID: https://orcid.org/0000-0003-3831-901X)
- Xue Meng (ORCID: https://orcid.org/0000-0001-9269-6073)
Institutions
- Peking University (CN)
- Tianjin Medical University General Hospital (CN)
- Seoul National University Bundang Hospital (KR)
- Beijing Hospital (CN)
- Peking University Sixth Hospital (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.092632
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00